Suppr超能文献

唾液中的脆弱拟杆菌:探究其与溃疡性结肠炎的关联

Bacteroides fragilis in saliva: investigating links with ulcerative colitis.

作者信息

Zamani Samin, Besharat Sima, Behnampour Nasser, Behnam Armina, Asgari Negar, Mortazavi Nazanin

机构信息

Department of Microbiology, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.

Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan, Iran.

出版信息

Braz J Microbiol. 2024 Dec;55(4):3691-3698. doi: 10.1007/s42770-024-01484-x. Epub 2024 Aug 19.

Abstract

BACKGROUND

Ulcerative colitis (UC) is a long-term bowel inflammation of unknown cause. Recent research points to gut microbiota, especially Enterotoxigenic Bacteroides fragilis (ETBF), in UC's development. This study examined the presence of Bacteroides fragilis (B. fragilis) and ETBF in the saliva of UC patients and Healthy Controls (HCs) in Iran.

METHODS

A total of 40 UC patients and 40 healthy controls were included in the study. Saliva samples were collected and analyzed for the presence of B. fragilis and ETBF using real-time polymerase chain reaction (PCR).

RESULTS

B. fragilis was more prevalent in HCs (70%) than UC patients (67.5%), but not significantly (p = 0.809). ETBF was significantly more prevalent in UC patients (50%) than HCs (10%) (p < 0.0001). The mean count of B. fragilis was higher in UC patients, but not significantly (p = 0.47). However, the mean count of ETBF was significantly higher in UC patients (p = 0.000089). In terms of gender, the number of B. fragilis in women was not significant (p = 0.16), but the number of ETBF was significantly higher in women with UC (p = 0.000458). For men, no significant differences were observed.

CONCLUSIONS

The present study suggest a higher prevalence of B. fragilis observed in UC patients compared to HCs. Further research is needed to confirm these findings and explore potential mechanisms underlying this association.

摘要

背景

溃疡性结肠炎(UC)是一种病因不明的慢性肠道炎症。近期研究表明肠道微生物群,尤其是产肠毒素脆弱拟杆菌(ETBF),在UC的发病过程中起作用。本研究检测了伊朗UC患者和健康对照者(HCs)唾液中脆弱拟杆菌(B. fragilis)和ETBF的存在情况。

方法

本研究共纳入40例UC患者和40例健康对照者。收集唾液样本,采用实时聚合酶链反应(PCR)分析B. fragilis和ETBF的存在情况。

结果

脆弱拟杆菌在HCs中的患病率(70%)高于UC患者(67.5%),但差异无统计学意义(p = 0.809)。ETBF在UC患者中的患病率(50%)显著高于HCs(10%)(p < 0.0001)。UC患者中脆弱拟杆菌的平均计数较高,但差异无统计学意义(p = 0.47)。然而,UC患者中ETBF的平均计数显著更高(p = 0.000089)。在性别方面,女性中脆弱拟杆菌的数量差异无统计学意义(p = 0.16),但UC女性患者中ETBF的数量显著更高(p = 0.000458)。男性中未观察到显著差异。

结论

本研究表明,与HCs相比,UC患者中脆弱拟杆菌的患病率更高。需要进一步研究来证实这些发现,并探索这种关联背后的潜在机制。

相似文献

1
Bacteroides fragilis in saliva: investigating links with ulcerative colitis.
Braz J Microbiol. 2024 Dec;55(4):3691-3698. doi: 10.1007/s42770-024-01484-x. Epub 2024 Aug 19.
2
The impact of biological interventions for ulcerative colitis on health-related quality of life.
Cochrane Database Syst Rev. 2015 Sep 22;2015(9):CD008655. doi: 10.1002/14651858.CD008655.pub3.
3
Enterotoxigenic : A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions.
Front Cell Infect Microbiol. 2020 Jan 17;9:449. doi: 10.3389/fcimb.2019.00449. eCollection 2019.
4
A systematic review of vedolizumab in treating pediatric ulcerative colitis: efficacy and safety insights.
Therap Adv Gastroenterol. 2025 Jul 23;18:17562848251356063. doi: 10.1177/17562848251356063. eCollection 2025.
5
Microbiota DNA Translocation Into Mesentery Lymph Nodes Is Associated With Early Development of Pouchitis After IPAA for Ulcerative Colitis.
Dis Colon Rectum. 2023 Nov 1;66(11):e1107-e1118. doi: 10.1097/DCR.0000000000002568. Epub 2022 Dec 22.
6
Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
Cochrane Database Syst Rev. 2008 Apr 16(2):CD006774. doi: 10.1002/14651858.CD006774.pub2.
8
Cyclosporine A for induction of remission in severe ulcerative colitis.
Cochrane Database Syst Rev. 2005 Jan 25(1):CD004277. doi: 10.1002/14651858.CD004277.pub2.
10
Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.
Cochrane Database Syst Rev. 2017 Sep 8;9(9):CD011572. doi: 10.1002/14651858.CD011572.pub2.

本文引用的文献

1
Trends of inflammatory bowel disease from the Global Burden of Disease Study (1990-2019).
Indian J Gastroenterol. 2024 Feb;43(1):188-198. doi: 10.1007/s12664-023-01430-z. Epub 2023 Oct 3.
2
Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases.
Metabolites. 2023 Jul 27;13(8):889. doi: 10.3390/metabo13080889.
3
Impact of gut Microbiome alteration in Ulcerative Colitis patients on disease severity and outcome.
Clin Exp Med. 2023 Sep;23(5):1763-1772. doi: 10.1007/s10238-022-00917-x. Epub 2022 Nov 7.
9
Association of the microbiome with colorectal cancer development (Review).
Int J Oncol. 2021 May;58(5). doi: 10.3892/ijo.2021.5197. Epub 2021 Mar 24.
10
Gut species in health and disease.
Gut Microbes. 2021 Jan-Dec;13(1):1-20. doi: 10.1080/19490976.2020.1848158.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验